You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Medtronic
Merck
McKesson
Colorcon

Last Updated: February 18, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 205636


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 205636 describes PROAIR RESPICLICK, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug. Additional details are available on the PROAIR RESPICLICK profile page.

The generic ingredient in PROAIR RESPICLICK is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
Summary for 205636
Tradename:PROAIR RESPICLICK
Applicant:Teva Branded Pharm
Ingredient:albuterol sulfate
Patents:15
Formulation / Manufacturing:see details
Pharmacology for NDA: 205636
Mechanism of ActionAdrenergic beta2-Agonists
Suppliers and Packaging for NDA: 205636
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PROAIR DIGIHALER albuterol sulfate POWDER, METERED;INHALATION 205636 NDA Teva Respiratory, LLC 59310-117 59310-117-20 1 INHALER in 1 BOX (59310-117-20) > 200 INHALANT in 1 INHALER
PROAIR RESPICLICK albuterol sulfate POWDER, METERED;INHALATION 205636 NDA Teva Respiratory, LLC 59310-117 59310-117-20 1 INHALER in 1 BOX (59310-117-20) > 200 INHALANT in 1 INHALER

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER, METERED;INHALATIONStrengthEQ 0.09MG BASE/INH
Approval Date:Mar 31, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Apr 28, 2019
Regulatory Exclusivity Use:NEW PATIENT POPULATION
Patent:  Start TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?
Patent:  Start TrialPatent Expiration:May 18, 2031Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Moodys
Johnson and Johnson
McKesson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.